Enovisの財務見通しに関する詳細な洞察と追加のProTipsについては、投資家はInvestingProで独占的に利用可能な包括的なProリサーチレポートにアクセスできます。 この記事の情報はプレスリリースの声明に基づいています。 その他の最近のニュースでは、Enovisは ...

2022年、製造技術事業のスピンオフに伴い、名称を「Colfax Corporation」→「Enovis Corporation」、ティッカーを「CFX」→「ENOV」に変更した。（2024/04/25 ...

Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

In a report released yesterday, Vik Chopra from Wells Fargo reiterated a Buy rating on Enovis (ENOV – Research Report), with a price target of ...

The information in this article is based on a press release statement. In other recent news, Enovis reported a significant year-over-year revenue increase of 21%, reaching $505 million in its ...

For detailed insights and additional ProTips about Enovis's financial outlook, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro. The information in ...

For detailed insights and additional ProTips about Enovis’s financial outlook, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro. The information in ...